Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...
Adequate lymph node yield for patients with papillary thyroid cancer is associated with longer operations, longer hospitalization, and higher risk of recurrent laryngeal nerve injury and hypocalcemia, ...
When it comes to cancer, the general idea is less is more. The fewer tumor and malignant cells that are left behind by treatment, the greater the chances of surviving the disease. Now a groundbreaking ...
University of Queensland researchers have received a $3.1 million grant for a trial which could revolutionize endometrial cancer treatment. Research Director Professor Andreas Obermair at UQ's ...
Please provide your email address to receive an email when new articles are posted on . Among patients with T1 colorectal cancer, deep submucosal invasion was not a significant independent predictor ...
A multicenter study led from Finland has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery.
Lymph node dissections, or lymphadenectomies, are surgical procedures that play an important role in cancer treatments. A healthcare professional will remove the lymph nodes and check a tissue sample ...
Active surveillance in sentinel lymph node positive melanoma could delay surgery but may result in the same risk of the cancer coming back. Ultrasound monitoring may be an alternative to surgical ...
CHICAGO Many breast cancer patients can skip aggressive lymph node surgery without increasing their chances of a recurrence or death if their disease shows limited spread, according to a study that ...
A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to ...
Surgery involving sentinel lymph node biopsy for middle-aged women with estrogen receptor-positive (ER+) breast cancer may do more harm than good, according to a new study led by University of ...